BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia X, Liang Q, Chi F, Cao W. Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses 2012;55:404-9. [PMID: 21999222 DOI: 10.1111/j.1439-0507.2011.02132.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Adoubryn K, N’gattia V, Kouadio-yapo G, Nigué L, Zika D, Ouhon J. Épidémiologie des otomycoses au centre hospitalier et universitaire de Yopougon (Abidjan-Côte d’Ivoire). Journal de Mycologie Médicale 2014;24:e9-e15. [DOI: 10.1016/j.mycmed.2013.07.057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Tasić-Otašević S, Golubović M, Đenić S, Ignjatović A, Stalević M, Momčilović S, Bojanović M, Arsić-Arsenijević V. Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia. J Mycol Med 2020;30:101011. [PMID: 32693980 DOI: 10.1016/j.mycmed.2020.101011] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in iran: a review. Mycopathologia 2015;179:415-24. [PMID: 25633436 DOI: 10.1007/s11046-015-9864-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
4 Yassine M, Haiet AH. Self-injury in schizophrenia as predisposing factor for otomycosis. Med Mycol Case Rep 2018;21:52-3. [PMID: 30069425 DOI: 10.1016/j.mmcr.2018.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang L, Wang X, Houbraken J, Mei H, Liao W, Hasimu H, Liu W, Deng S. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China. Mycopathologia 2020;185:527-35. [DOI: 10.1007/s11046-020-00448-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kiakojuri K, Mahdavi Omran S, Roodgari S, Taghizadeh Armaki M, Hedayati MT, Shokohi T, Haghani I, Javidnia J, Kermani F, Badali H, Abastabar M. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis. Mycopathologia 2021;186:245-57. [PMID: 33718990 DOI: 10.1007/s11046-021-00537-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hagiwara S, Tamura T, Satoh K, Kamewada H, Nakano M, Shinden S, Yamaguchi H, Makimura K. The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan. Mycopathologia 2019;184:13-21. [PMID: 30291485 DOI: 10.1007/s11046-018-0299-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
8 Luo W, Wu J, Peng KA, Li Q, Du Q, Xu J, Dai C, Chi F, Shu Y. Clinical Characteristics of Patients With Papilloma in the External Auditory Canal. Laryngoscope 2021;131:1132-7. [PMID: 33030216 DOI: 10.1002/lary.29113] [Reference Citation Analysis]
9 Navaneethan N, YaadhavaKrishnan RP. Type of Antifungals: Does it Matter in Empirical Treatment of Otomycosis? Indian J Otolaryngol Head Neck Surg 2015;67:64-7. [PMID: 25621236 DOI: 10.1007/s12070-014-0780-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Ismail MT, Al-Kafri A, Ismail M. Otomycosis in Damascus, Syria: Etiology and clinical features. Curr Med Mycol 2017;3:27-30. [PMID: 29707671 DOI: 10.29252/cmm.3.3.27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
11 Lou Z. The evaluation of endoscopic cartilage myringoplasty to repair perforations with otomycosis. Am J Otolaryngol 2020;41:102493. [PMID: 32334921 DOI: 10.1016/j.amjoto.2020.102493] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Philip A, Thomas R, Job A, Sundaresan VR, Anandan S, Albert RR. Effectiveness of 7.5 percent povidone iodine in comparison to 1 percent clotrimazole with lignocaine in the treatment of otomycosis. ISRN Otolaryngol 2013;2013:239730. [PMID: 23984100 DOI: 10.1155/2013/239730] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
13 Kamali Sarwestani Z, Hashemi SJ, Rezaie S, Gerami Shoar M, Mahmoudi S, Elahi M, Bahardoost M, Tajdini A, Abutalebian S, Daie Ghazvini R. Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients. J Mycol Med 2018;28:279-84. [PMID: 29540288 DOI: 10.1016/j.mycmed.2018.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
14 Li Y, He L. Diagnosis and treatment of otomycosis in southern China. Mycoses 2019;62:1064-8. [PMID: 31368588 DOI: 10.1111/myc.12979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
15 Merad Y, Derrar H, Belmokhtar Z, Belkacemi M. Aspergillus Genus and Its Various Human Superficial and Cutaneous Features. Pathogens 2021;10:643. [PMID: 34071092 DOI: 10.3390/pathogens10060643] [Reference Citation Analysis]
16 Westby D, O'Connell N, Powell J, Fenton JE. The changing nature of paediatric otomycosis in the mid-west of Ireland. J Laryngol Otol 2020;134:592-6. [PMID: 32713390 DOI: 10.1017/S0022215120001164] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Prasad SC, Kotigadde S, Shekhar M, Thada ND, Prabhu P, D' Souza T, Prasad KC. Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification. Int J Microbiol 2014;2014:636493. [PMID: 24949016 DOI: 10.1155/2014/636493] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
18 Chen Q, Chu H, Tao Y, Peng L, Zhou L, Liu L, Wu X. A Comparison of Triamcinolone Acetonide Econazole Cream and Nystatin Suspension in Treatment of Otomycosis. Laryngoscope 2021;131:E1640-6. [PMID: 33141477 DOI: 10.1002/lary.29190] [Reference Citation Analysis]
19 Kiakojuri K, Rajabnia R, Jalili B, Khafri S, Omran SM. Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran. Jundishapur J Microbiol 2015;8:e17138. [PMID: 26060563 DOI: 10.5812/jjm.8(5)2015.17138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
20 Jing R, Yang WH, Xiao M, Li Y, Zou GL, Wang CY, Li XW, Xu YC, Hsueh PR. Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China. J Microbiol Immunol Infect 2021:S1684-1182(21)00063-3. [PMID: 33839057 DOI: 10.1016/j.jmii.2021.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Cheraghsahar S, Kazemi S, Birjandi M, Yarahmadi M, Mahmoudi S, Mohammadi R, Sepahvand A. Otomycosis in Western Iran: Clinical and Mycological Aspects. Arch Clin Infect Dis 2017;In Press. [DOI: 10.5812/archcid.57287] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Punia RS, Singhal SK, Kundu R, Das A, Chander J. Fungal Suppurative Otitis Media (Histopathology) Among Patients in North India. Head Neck Pathol 2019;13:149-53. [PMID: 29671212 DOI: 10.1007/s12105-018-0918-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
23 Gharaghani M, Halvaeezadeh M, Ali Jalaee G, Taghipour S, Kiasat N, Zarei Mahmoudabadi A. Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran. Curr Med Mycol 2020;6:18-22. [PMID: 33628977 DOI: 10.18502/CMM.6.2.2696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Kiakojuri K, Rajabnia R, Mahdavi Omran S, Pournajaf A, Karami M, Taghizadeh Armaki M. Role of Clotrimazole in Prevention of Recurrent Otomycosis. Biomed Res Int 2019;2019:5269535. [PMID: 31950041 DOI: 10.1155/2019/5269535] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Aboutalebian S, Mahmoudi S, Mirhendi H, Okhovat A, Abtahi H, Chabavizadeh J. Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agents. J Med Microbiol 2019;68:918-23. [PMID: 31063125 DOI: 10.1099/jmm.0.000985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
26 Sangaré I, Amona FM, Ouedraogo RW, Zida A, Ouedraogo MS. Otomycosis in Africa: Epidemiology, diagnosis and treatment. J Mycol Med 2021;31:101115. [PMID: 33516991 DOI: 10.1016/j.mycmed.2021.101115] [Reference Citation Analysis]
27 Wu S, Cheng Y, Lin S, Liu H. A Comparison of Antifungal Drugs and Traditional Antiseptic Medication for Otomycosis Treatment: A Systematic Review and Meta-Analysis. Front Surg 2021;8:739360. [PMID: 35004834 DOI: 10.3389/fsurg.2021.739360] [Reference Citation Analysis]
28 Ahmed MR, Abou-Halawa AS, Hessam WF, Abdelkader DSA. A search for new otomycotic species and their sensitivity to different antifungals. Interv Med Appl Sci 2018;10:145-9. [PMID: 30713753 DOI: 10.1556/1646.10.2018.28] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Alarid-Coronel J, Celis-Aguilar E, Escobar-Aispuro L, Muñoz-Estrada V. Otomycosis in immunocompetent patients: Clinical and mycological features. Our experience with 40 cases. Clin Otolaryngol 2018;43:373-7. [PMID: 28834405 DOI: 10.1111/coa.12966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
30 Mahdavi Omran S, Yousefzade Z, Khafri S, Taghizadeh-Armaki M, Kiakojuri K. Effect of combination therapy with ceftizoxime and clotrimazole in the treatment of otomycosis. Curr Med Mycol 2018;4:18-23. [PMID: 30186989 DOI: 10.18502/cmm.4.1.30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Aboutalebian S, Mahmoudi S, Okhovat A, Khodavaisy S, Mirhendi H. Otomycosis Due to the Rare Fungi Talaromyces purpurogenus, Naganishia albida and Filobasidium magnum. Mycopathologia 2020;185:569-75. [PMID: 32232764 DOI: 10.1007/s11046-020-00439-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
32 Yang B, Zhang L, Chen X. Evaluation and comparison of tympanoplasty efficacy with tympanic membrane perforation after chronic suppurative otitis media in dry ear with different microorganisms. Am J Otolaryngol 2021;42:102900. [PMID: 33454455 DOI: 10.1016/j.amjoto.2021.102900] [Reference Citation Analysis]
33 Koltsidopoulos P, Skoulakis C. Otomycosis With Tympanic Membrane Perforation: A Review of the Literature. Ear Nose Throat J 2020;99:518-21. [PMID: 31142158 DOI: 10.1177/0145561319851499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Lam P, Lee KK, Kok SH, Gambari R, Lam K, Ho C, Ma X, Lo Y, Wong W, Dong Q, Bian Z, Chui C. Antifungal study of substituted 4-pyridylmethylene-4′-aniline Schiff bases. RSC Adv 2016;6:104575-81. [DOI: 10.1039/c6ra20186e] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]